(Q37783572)

English

Tivozanib, a pan-VEGFR tyrosine kinase inhibitor for the potential treatment of solid tumors.

scientific article published on September 2010

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20799147

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20799147%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

title

Tivozanib, a pan-VEGFR tyrosine kinase inhibitor for the potential treatment of solid tumors (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20799147

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20799147%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

Antonella De Luca

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20799147

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20799147%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

Nicola Normanno

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20799147

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20799147%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

publication date

1 September 2010

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20799147

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20799147%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

published in

IDrugs: the Investigational Drugs Journal

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20799147

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20799147%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

volume

13

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20799147

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20799147%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

issue

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20799147

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20799147%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

page(s)

636-645

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20799147

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20799147%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

Identifiers

PubMed publication ID

20799147

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20799147

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20799147%20AND%20SRC:MED&resulttype=core&format=json

(Q37783572)

Tivozanib, a pan-VEGFR tyrosine kinase inhibitor for the potential treatment of solid tumors.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)